From PharmaLive: Abbott Laboratories said it signed a worldwide licensing agreement with French drugmaker Pierre Fabre SA to develop and market an antibody targeting the cMet receptor for the treatment of cancer.
Read the story: pharmalive.com
«
Back to home
This is the archives. For recent stories visit chicagobreakingbusiness.com »
Thank You, good material. Helped me write some posts on dog training tricks. Added your article to my bookmarks.